DAIC

MAY 16, 2024

Apparent treatment-resistant hypertension is defined as the need to take three or more types of anti-high blood pressure medication daily and is associated with an increased risk for stroke , coronary heart disease , heart failure , and all-cause mortality.

Hypertension 105

Hypertension Blood Pressure Health Disparities Heart Attack 105

Wellnest

DECEMBER 31, 2023

1 poses an increased risk to public health compared to other circulating variants. Can COVID-19 symptoms mimic a heart attack? Yes, COVID-19 symptoms can resemble a heart attack, including chest pain, shortness of breath, and changes in echocardiogram or EKG. Risk posed by JN.1

COVID-19 52

COVID-19 Heart Attack Heart attacks Exercise 52

DAIC

AUGUST 21, 2024

The results were calculated using a new, proposed risk prediction scale for heart failure specifically for American Indian adults. and a researcher at Columbia University’s Mailman School of Public Health in New York City. and a researcher at Columbia University’s Mailman School of Public Health in New York City.

Heart Failure 52

Heart Failure Risk Factors Heart Attack Heart attacks 52

DAIC

MAY 16, 2024

A new joint guideline from the American Heart Association (AHA), the American College of Cardiology (ACC) and nine other medical societies reports early diagnosis and treatment of peripheral artery disease is essential to improve outcomes and reduce amputation risk, heart attack, stroke and death for people with Peripheral Artery Disease (PAD).

Peripheral Arterial Disease 105

Peripheral Arterial Disease Exercise Ischemia Quality of Life 105

Dr. Malcolm Kendrick

OCTOBER 20, 2023

They would have their blood pressure measured and put on antihypertensives. Anyone with diabetes would be prescribed blood sugar lowering medications. For example, the percentage of their patients with high blood pressure where it is successfully lowered to achieve the required level e.g., < 140/90mmHg – or less 1.

Heart Attack 52

Heart Attack Heart attacks Blood Pressure ACE Inhibitor 52

DAIC

MARCH 8, 2024

Food and Drug Administration ( FDA ) has approved an additional indication for Wegovy ( semaglutide ) to reduce the risk of major cardiovascular events such as death, heart attack, or stroke in adults with known heart disease and with either obesity or overweight along with a reduced calorie diet and increased physical activity.

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111